Nexpoint Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Nexpoint Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,039,280	Closed	-$29.5M	–	86
2026 Q1	$29.5M	Buy	+2,039,280	New	+$29.2M	1.98%	18
2021 Q3	–	Sell	-56,617	Closed	-$546K	–	182
2021 Q2	$546K	Hold	56,617	–	–	0.12%	88
2021 Q1	$559K	Sell	56,617 -633	-1%	-$9.8K	0.15%	84
2020 Q4	$1.32M	Hold	57,250	–	–	0.43%	58
2020 Q3	$808K	Sell	57,250 -8,450	-13%	-$123K	0.18%	87
2020 Q2	$991K	Hold	65,700	–	–	0.22%	74
2020 Q1	$607K	Hold	65,700	–	–	0.11%	113
2019 Q4	$640K	Hold	65,700	–	–	0.05%	175
2019 Q3	$527K	Buy	+65,700	New	+$713K	0.03%	244

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Nexpoint Asset Management's FOLD Position: Q2 2026 in Review

Nexpoint Asset Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 2,039,280 shares — an estimated $29.5M sold.

Nexpoint Asset Management first reported a position in FOLD in Q3 2019 and held it in 9 quarters. The position peaked at $29.5M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Nexpoint Asset Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Nexpoint Asset Management sold 2,039,280 Amicus Therapeutics shares in Q2 2026, an estimated $29.5M.
Nexpoint Asset Management first reported a position in Amicus Therapeutics in Q3 2019 and held it in 9 quarters.
Nexpoint Asset Management's Amicus Therapeutics position peaked at $29.5M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Nexpoint Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.